Click 'Attend' above to register.
Feedyard veterinarians are tasked with selecting a metaphylaxis antimicrobial approved to control bovine respiratory disease (BRD) in high-risk animals. Often overlooked as a criterion for metaphylaxis selection is the rate of first-treatment success after an initial BRD episode occurring subsequent to the post-metaphylactic interval (PMI).
A pivotal factor determining profit or loss is the ability for metaphylactically managed cattle to favorably respond to initial BRD treatment and rejoin penmates at the bunk. BRD re-treats and chronics can quickly elevate production costs and drain profit potential.
The webinar will review studies examining first-treatment success following metaphylaxis, and help control BRD in high-risk stocker and feedlot cattle. Also learn about solutions that you can implement when antibiotics fail to meet expectations.
What you will learn:
- Examine first-treatment success following metaphylaxis to help control BRD in high-risk stocker and feedlot cattle.
- Review 12 studies showing how metaphylactically managed cattle respond to initial BRD treatment and quickly rejoin penmates.
- Select a metaphylaxis product to help reduce medical expenses, performance losses and input costs associated with recurring BRD to optimize profit potential.
- Discover solutions that can be implemented when antibiotics fail to meet expectations.
Who should attend:
- Feedlot veterinarians
- Stocker veterinarians